149 related articles for article (PubMed ID: 35041489)
21. Geographic Variation In Effective Contraceptive Use Among Medicaid Recipients In 2018.
Rodriguez MI; Meath THA; Watson K; Daly A; Tracy K; McConnell KJ
Health Aff (Millwood); 2023 Apr; 42(4):537-545. PubMed ID: 37011322
[TBL] [Abstract][Full Text] [Related]
22. Medicaid Payment For Postpartum Long-Acting Reversible Contraception Prompts More Equitable Use.
Quinlan TAG; Lindrooth RC; Guiahi M; McManus BM; Mays GP
Health Aff (Millwood); 2023 May; 42(5):665-673. PubMed ID: 37126756
[TBL] [Abstract][Full Text] [Related]
23. Special report: implementing immediate postpartum LARC in Florida.
Brown JA; Greenfield LT; Rapkin RB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S906-S909. PubMed ID: 31866518
[TBL] [Abstract][Full Text] [Related]
24. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
[TBL] [Abstract][Full Text] [Related]
25. From uptake to access: a decade of learning from the ACOG LARC program.
Horvath S; Bumpus M; Luchowski A
Am J Obstet Gynecol; 2020 Apr; 222(4S):S866-S868.e1. PubMed ID: 31794720
[TBL] [Abstract][Full Text] [Related]
26. Association of Medicaid Reimbursement for Immediate Postpartum Long-acting Reversible Contraception With Infant Birth Outcomes.
Steenland MW; Pace LE; Cohen JL
JAMA Pediatr; 2022 Mar; 176(3):296-303. PubMed ID: 35006260
[TBL] [Abstract][Full Text] [Related]
27. Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations.
Liberty A; Yee K; Darney BG; Lopez-Defede A; Rodriguez MI
Am J Obstet Gynecol; 2020 Apr; 222(4S):S886.e1-S886.e9. PubMed ID: 31846612
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception.
Aligne CA; Phelps R; VanScott JL; Korones SA; Greenberg KB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S890.e1-S890.e6. PubMed ID: 31978438
[TBL] [Abstract][Full Text] [Related]
29. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
30. Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients.
Rodriguez MI; Meath T; Huang J; Darney BG; McConnell KJ
Contraception; 2021 Nov; 104(5):571-576. PubMed ID: 34224694
[TBL] [Abstract][Full Text] [Related]
31. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
; Vricella LK; Gawron LM; Louis JM
Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
[TBL] [Abstract][Full Text] [Related]
32. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
[TBL] [Abstract][Full Text] [Related]
33. Revolving Loan Fund: A Novel Approach to Increasing Access to Long-Acting Reversible Contraception Methods in Community Health Centers.
Evans ML; Breeze JL; Paulus JK; Meadows A
J Public Health Manag Pract; 2017; 23(6):684-689. PubMed ID: 28628582
[TBL] [Abstract][Full Text] [Related]
34. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists.
Castleberry NM; Stark L; Schulkin J; Grossman D
Contraception; 2019 Aug; 100(2):123-127. PubMed ID: 30981843
[TBL] [Abstract][Full Text] [Related]
35. Cost Minimization Analysis of Same-Day Long-Acting Reversible Contraception for Adolescents.
Wilkinson TA; Downs SM; Tucker Edmonds B
JAMA Netw Open; 2019 Sep; 2(9):e1911063. PubMed ID: 31509208
[TBL] [Abstract][Full Text] [Related]
36. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
Coates C; Gordon CM; Simpson T
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
[TBL] [Abstract][Full Text] [Related]
37. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs).
Beeson T; Wood S; Bruen B; Goldberg DG; Mead H; Rosenbaum S
Contraception; 2014 Feb; 89(2):91-6. PubMed ID: 24210278
[TBL] [Abstract][Full Text] [Related]
38. Development and Uptake of Long-Acting Reversible Contraception Services in Rwanda, 2009-2016.
Ingabire R; Mukamuyango J; Nyombayire J; Easter SR; Parker R; Mazzei A; Sinabamenye R; Tichacek A; Allen S; Karita E; Wall KM
J Womens Health (Larchmt); 2019 Dec; 28(12):1640-1649. PubMed ID: 31274397
[No Abstract] [Full Text] [Related]
39. Projections and opinions from 100 experts in long-acting reversible contraception.
Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
[TBL] [Abstract][Full Text] [Related]
40. Insights in Public Health: Insurance Coverage for Long-Acting Reversible Contraception Placed in Office: A Buy and Bill Demonstration Project in Hawai'i.
Davis CMA; Kaneshiro B; Tschann M
Hawaii J Health Soc Welf; 2020 Oct; 79(10):312-316. PubMed ID: 33047106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
